Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism PI3K family inhibitors(Phosphatidylinositol 3-kinase family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | - | 02 May 2024 | |
Autoimmune Diseases | Discovery | - | 02 May 2024 | |
Congenital Disorders | Discovery | - | 02 May 2024 | |
Congenital Disorders | Discovery | - | 02 May 2024 | |
Dermatophilosis | Discovery | - | 02 May 2024 | |
Dermatophilosis | Discovery | - | 02 May 2024 | |
Glomerulonephritis | Discovery | - | 02 May 2024 | |
Glomerulonephritis | Discovery | - | 02 May 2024 | |
Keloid | Discovery | - | 02 May 2024 | |
Keloid | Discovery | - | 02 May 2024 |